Clinical trial
Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric…
NCT00302640 · Romark Laboratories L.C., Industry · Completed
Key facts
| NCT number | NCT00302640 |
|---|---|
| Title | Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children |
| Official title | Multi-center, Double-blind, Placebo-controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Rotavirus Infection, Adenoviridae Infection, Norovirus Infection |
| Intervention type | Drug |
| Interventions | Alinia (nitazoxanide) |
| Enrollment | 50 |
| Start date | Feb 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Mar 14, 2006 |
| Last update posted | May 31, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: